Published in
Elsevier, Pharmacological Research, (175), p. 105997, 2022
DOI: 10.1016/j.phrs.2021.105997
Links
Tools
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment
Journal article published in 2022 by
Lucia Lisi,
Pedro Miguel Lacal,
Maria Martire,
Pierluigi Navarra,
Grazia Graziani 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 